Novavax
NVAX | NASDAQ
$8.06
-$0.46 (-5.45%)
At close: Nov 16, 2026, 4:00 PM ET
$8.07
+$0.01 (+0.14%)
After-hours:
Nov 16, 2026, 7:50 PM ET
Novavax Statistics
Key statistics explainedMarket Data
$1.33B
$999.7M
2.72
5.53M
164.92M
1.58%
72.73%
NASDAQ
US6700024010
Price Performance
-28.4%
-0.1%
-9.7%
19.9%
18.5%
40.7%
-95.6%
-28.4%
15.6%
-45.1%
-11.6%
Valuation
-17.52
125.25
0.29
0.18
3.23
5.40
-6.13
-5.44
-4.81
-5.52
2.43
-19.95
-27.90
-4.09
-5.7%
-18.4%
-20.8%
Financial Health
$330.28M
$292.09M
$622.36M
$888.01M
2.15
2.09
-1.36
-8.15
-1.19
-0.83
-6.71
-5.80
0
Margins & Profitability
77.3%
-19.6%
-8.7%
-18.6%
-59.4%
-67.1%
7.7%
-13.0%
Returns
-8.6%
45.1%
-14.4%
-14.4%
-9.9%
Historical Growth (CAGR)
-17.3%
-19.3%
38.5%
284.2%
85.0%
17.8%
-26.8%
29.5%
-14.8%
Analyst Forecasts
Hold
6
144.2%
8.8%
Feb 25, 2027
$0.54
392.7%
$216M
46.8%
Fair Value Estimates
N/A
N/A
N/A
N/A
$8.00
-0.7%
Cash Flow
$-241.55M
$-244.64M
$-276.38M
-$1.48
-$1.46
-58.7%
Income Statement
$411.65M
$318.02M
$-80.6M
$-35.83M
$-76.73M
-$0.46
$549.6K
$-102.44K
749
Add to Watchlist
Select watchlists to add or remove NVAX